Rocket One Inc. Stock-Based Compensation
Rocket One Inc. (RKTO) reported Stock-Based Compensation of $625.49 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- Rocket One Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Rocket One Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $968.00K, a 241.65% increase year-over-year.
- Rocket One Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Rocket One Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $219.93K, a 57.16% decline year-over-year.
- Rocket One Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $1.19M, a 47.70% increase from fiscal 2024.
- Rocket One Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $804.28K, a 271.61% increase from fiscal 2023.
- Rocket One Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $216.43K, a 65.14% decline from fiscal 2022.
- Rocket One Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $620.80K, a 53.07% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 8 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $625.49K 10-Q · filed 2026-08-14 | ||||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $968.00K derived: sum of 2 quarters · filed 2026-03-27 | $968.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.19M 10-K · filed 2026-03-27 | |||
| 2025-09-30 | $968.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $968.00K derived: sum of 2 quarters · filed 2026-08-14 | $1.19M 10-Q · filed 2025-11-12 | $1.19M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $219.93K 10-Q · filed 2026-08-14 | $220.47K derived: sum of 3 quarters · filed 2026-08-14 | $503.80K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $219.93K 10-Q · filed 2026-05-15 | $220.47K derived: sum of 2 quarters · filed 2026-05-15 | $503.80K derived: sum of 3 quarters · filed 2026-05-15 | $510.86K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $541.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $283.87K derived: sum of 2 quarters · filed 2026-03-27 | $290.93K derived: sum of 3 quarters · filed 2026-03-27 | $804.28K 10-K · filed 2026-03-27 | |||
| 2024-09-30 | $283.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $290.39K derived: sum of 2 quarters · filed 2025-11-12 | $803.74K 10-Q · filed 2025-11-12 | $809.52K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $7.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $520.40K 10-Q · filed 2025-08-12 | $526.19K derived: sum of 3 quarters · filed 2025-08-12 | $716.45K derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $513.35K 10-Q · filed 2025-05-12 | $519.13K derived: sum of 2 quarters · filed 2025-05-12 | $709.40K derived: sum of 3 quarters · filed 2025-05-12 | $719.15K derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $5.79K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $196.05K derived: sum of 2 quarters · filed 2025-03-28 | $205.80K derived: sum of 3 quarters · filed 2025-03-28 | $216.43K 10-K · filed 2025-03-28 | |||
| 2023-09-30 | $190.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $200.01K derived: sum of 2 quarters · filed 2024-11-12 | $210.64K 10-Q · filed 2024-11-12 | $226.11K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $9.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $20.38K 10-Q · filed 2024-08-09 | $35.85K derived: sum of 3 quarters · filed 2024-08-09 | $48.20K derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | $10.63K 10-Q · filed 2024-05-14 | $26.10K derived: sum of 2 quarters · filed 2024-05-14 | $38.45K derived: sum of 3 quarters · filed 2024-05-14 | $53.99K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $15.47K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $27.82K derived: sum of 2 quarters · filed 2024-03-28 | $43.36K derived: sum of 3 quarters · filed 2024-03-28 | $620.80K 10-K · filed 2024-03-28 | |||
| 2022-09-30 | $12.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $27.89K derived: sum of 2 quarters · filed 2023-11-13 | $605.33K 10-Q · filed 2023-11-13 | $747.85K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $15.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $592.98K 10-Q · filed 2023-08-11 | $700.00 10-Q · filed 2022-08-12 | $735.50K derived: sum of 3 quarters · filed 2023-08-11 | $759.40K derived: sum of 4 quarters · filed 2023-08-11 | ||
| 2022-03-31 | $577.44K 10-Q · filed 2023-05-15 | $1.30K 10-Q · filed 2022-05-12 | $719.96K derived: sum of 2 quarters · filed 2023-05-15 | $743.86K derived: sum of 3 quarters · filed 2023-05-15 | $774.22K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $142.52K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $166.42K derived: sum of 2 quarters · filed 2023-03-31 | $196.78K derived: sum of 3 quarters · filed 2023-03-31 | $1.32M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $23.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $54.26K derived: sum of 2 quarters · filed 2022-11-10 | $1.18M 10-Q · filed 2022-11-10 | $1.22M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $30.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $1.16M 10-Q · filed 2021-08-11 | $1.19M derived: sum of 3 quarters · filed 2021-08-11 | $1.89M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2021-03-31 | $1.13M 10-Q · filed 2021-05-13 | $1.16M derived: sum of 2 quarters · filed 2021-05-13 | $1.86M derived: sum of 3 quarters · filed 2021-11-10 | $1.84M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-12-31 | $36.84K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $729.98K derived: sum of 2 quarters · filed 2021-11-10 | $714.05K derived: sum of 3 quarters · filed 2021-11-10 | $737.75K 10-K · filed 2021-03-16 | |||
| 2020-09-30 | $693.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $677.21K derived: sum of 2 quarters · filed 2021-11-10 | $700.91K 10-Q · filed 2021-11-10 | $2.70M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | -$15.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $7.76K 10-Q · filed 2021-08-11 | $2.01M derived: sum of 3 quarters · filed 2021-08-11 | $2.21M derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-31 | $23.70K 10-Q · filed 2021-05-13 | $2.02M derived: sum of 2 quarters · filed 2021-05-13 | $2.23M derived: sum of 3 quarters · filed 2021-05-13 | $2.32M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $2.21M derived: sum of 2 quarters · filed 2021-03-16 | $2.29M derived: sum of 3 quarters · filed 2021-03-16 | $2.50M 10-K · filed 2021-03-16 | |||
| 2019-09-30 | $206.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $294.13K derived: sum of 2 quarters · filed 2020-11-10 | $496.84K 10-Q · filed 2020-11-10 | $501.80K derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | $87.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $290.07K 10-Q · filed 2020-08-13 | $295.04K derived: sum of 3 quarters · filed 2020-08-13 | $300.63K derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | $202.71K 10-Q · filed 2020-05-13 | $207.67K derived: sum of 2 quarters · filed 2020-05-13 | $213.26K derived: sum of 3 quarters · filed 2020-05-13 | $330.76K derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | $4.96K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $10.55K derived: sum of 2 quarters · filed 2020-03-02 | $128.05K derived: sum of 3 quarters · filed 2020-03-02 | $143.05K 10-K · filed 2020-03-02 | |||
| 2018-09-30 | $5.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $123.09K derived: sum of 2 quarters · filed 2019-11-12 | $138.09K 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $117.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $132.50K 10-Q · filed 2019-08-14 | |||||
| 2018-03-31 | $15.00K 10-Q · filed 2019-05-15 | ||||||
| 2017-12-31 | $956.20K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |